Abbott Laboratories (ABT) stock
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3034% above fair value
$104.71−2.74 (-2.55%)
Close on Nov 17, 2026Market cap $181.19BP/E 33.7Yield 2.29%
Abbott Laboratories price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Abbott Laboratories's price to book ratio was 3.7× on Nov 11, 2026, against 4.4× a year earlier. Over the last 5 years it ranged from 2.9× to 7.3×, with a median of 4.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.7× | −0.6 |
| 2025 | Dec 31, 2025 | 4.3× | −0.7 |
| 2024 | Dec 31, 2024 | 5.0× | −0.2 |
| 2023 | Dec 29, 2023 | 5.1× | −0.3 |
| 2022 | Dec 30, 2022 | 5.5× | −1.9 |
| 2021 | Dec 31, 2021 | 7.3× | +1.1 |
| 2020 | Dec 31, 2020 | 6.2× | +1.4 |
| 2019 | Dec 31, 2019 | 4.9× | +0.7 |
| 2018 | Dec 31, 2018 | 4.2× | +1.2 |
| 2017 | Dec 29, 2017 | 3.0× | +0.3 |
| 2016 | Dec 30, 2016 | 2.7× | −0.5 |
| 2015 | Dec 31, 2015 | 3.2× | +0.2 |
| 2014 | Dec 31, 2014 | 3.0× | +0.5 |
| 2013 | Dec 31, 2013 | 2.6× | −1.3 |
| 2012 | Dec 31, 2012 | 3.8× | +0.3 |
| 2011 | Dec 30, 2011 | 3.6× | +0.1 |
| 2010 | Dec 31, 2010 | 3.5× | −0.5 |
| 2009 | Dec 31, 2009 | 3.9× | – |
See a number that looks wrong?